Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
06/05/2002
Trade Name:
Ritalin LA Capsules
Generic Name or Proper Name (*):
methylphenidate
Indications Studied:
Attention Deficit Hyperactivity Disorder
Label Changes Summary:
Approved for use in 6-12 years of age; once a day dose in the morning
Product Labeling:
Labeling
Pediatric Rule (R):
R
Sponsor:
Novartis
NNPS:
FALSE'
Therapeutic Category:
CNS Stimulant
-
-